Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Filer	Latest Filing Date	Share-Type	Shares	Market Value	Previously owned	Change
Freshford Capital Managemen...	2023-08-14	Shares	970.93K	19.49M	0	970.93K
Caspian Capital Lp	2023-08-14	Shares	333.12K	6.69M	402.20K	-69.08K
Ratan Capital Management Lp	2023-08-15	Shares	121.47K	2.44M	0	121.47K
Covalent Partners Llc	2023-08-14	Shares	12.20K	244.85K	12.20K	0

NYSE:BLCO

Bausch + Lomb Corporation

Last Close

16.00

30/08 20:00

Market Cap

5.43B

Beta: -

Volume Today

245.58K

Avg: 384.32K

PE Ratio

−23.54

PFCF: −321.80

Institutional trades

Institutional Ownership

Current holdings institutionals